WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF ATORVASTATIN CALCIUM BULK AND PHARMACEUTICAL FORMULATIONS

J.N.Suresh Kumar, Ch.Narendra Babu*, T.Dhanalakshmi, K.Florence,M.Sita Ramanjaneyulu, N.Sambasivanaik

ABSTRACT

Atorvastatin Calcium is hypolipidemic agent. In the present study, a simple, sensitive, rapid and economic and specific UVSpectrophotometric method has been developed and validated for the Atorvastatin Calcium in bulk and pharmaceutical dosage forms. The Atorvastatin Calcium stock solutions are prepared in methanol. The method of analysis is derivative spectroscopy to eliminate spectral interference by measuring absorbance at 247nm for Atorvastatin Calcium respectively. The Atorvastatin are linear in concentration range of 0-25μg/ml respectively. The absorption maxima was determined with 10μg/ml by scanning in the range of 200-400nm. The method was validation in terms of linearity, accuracy, range, precision, robustness, LOD and LOQ, system suitability, stability of analytical solution. Results of analysis were validated statistically. Percentage recovery studies are in the range of 99.92% to 99.58%. The LOD and LOQ of Atorvastatin were 0.998μg/ml and 3.025μg/ml respectively. From that it was observed that is no interference of blank, excipients during the estimation of drug in formulation. This shows the adaptability in pharmaceutical dosage forms.

Keywords: Atorvastatin, method development, validation, spectrophotometer.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More